Why In Vitro Biofilm Susceptibility Data Fail to Predict In Vivo Outcomes: Five Axes of Divergence and a Proposed Minimum Reporting Set
Microorganisms · 18.11.2026 · 14 (11) · 2675
DOI: 10.3390/microorganisms14112675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 18.11.2026. Verfasst von Mohammed Ibrahim Saeed und 2 weiteren Autor:innen. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Biofilm-associated infections impose a substantial burden on clinical practice, yet in vitro data generated to guide therapeutic development frequently fail to predict in vivo outcomes. This review advances a problem-solving argument: although host immunity, pharmacokinetics, tissue penetration, and infection-site biology also shape clinical outcomes, a major and modifiable contributor to this predictive failure is the systematic simplification of the measured object away from the resistance mechanisms operating within the infection microenvironment. Across five axes of divergence (surface, medium conditioning, operational steps, timing, and readout with controls), we identify gaps and failure modes that weaken the link between bench data and clinical outcome. Recent evidence shows that crystal violet and XTT staining report different biological parameters and agree with each other, and with viable counts, only under defined conditions; standardized parameters for minimum biofilm eradication concentration testing remain absent, and that growth mode, aggregation propensity, and growth rate, which vary between strains, strongly influence biofilm formation and resistance in ways conventional assays poorly capture. We propose a research agenda centered on physiologically conditioned platforms, multi-endpoint readouts, confounding controls, maturity-indexed endpoints, and growth-mode heterogeneity, offering a proposed, as yet unvalidated, minimum reporting framework intended to make assay conditions auditable and results comparable across studies, as a prerequisite for, rather than a demonstration of, clinical predictive validity.
Zitieren
APA
Saeed, M. I., Ali, S. M., & Mohamed, S. E. R. (2026). Why In Vitro Biofilm Susceptibility Data Fail to Predict In Vivo Outcomes: Five Axes of Divergence and a Proposed Minimum Reporting Set. Microorganisms, 14(11), 2675. https://doi.org/10.3390/microorganisms14112675
Vancouver
Saeed MI, Ali SM, Mohamed SER. Why In Vitro Biofilm Susceptibility Data Fail to Predict In Vivo Outcomes: Five Axes of Divergence and a Proposed Minimum Reporting Set. Microorganisms. 2026;14(11):2675. doi:10.3390/microorganisms14112675
BibTeX
@article{Saeed2026,
author = {Saeed, Mohammed Ibrahim and Ali, Sara Mohamed and Mohamed, Salma Elnour Rahma},
title = {Why In Vitro Biofilm Susceptibility Data Fail to Predict In Vivo Outcomes: Five Axes of Divergence and a Proposed Minimum Reporting Set},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {11},
pages = {2675},
doi = {10.3390/microorganisms14112675}
}
EUVIMED